Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(27%)
Results Posted
100%(6 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
4
36%
Ph phase_2
5
45%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
5(50.0%)
Phase 3Large-scale testing
4(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting2
Terminated1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 25 (50.0%)
Phase 34 (40.0%)

Trials by Status

completed655%
recruiting218%
terminated19%
active_not_recruiting19%
unknown19%

Recent Activity

3 active trials
Showing 5 of 11
recruitingphase_2

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

NCT03970447
completedphase_2

Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder

NCT03299166
unknown

Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)

NCT06034886
completedphase_3

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

NCT04641143
active_not_recruitingphase_3

Troriluzole in Adult Participants With Spinocerebellar Ataxia

NCT03701399
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03970447Phase 2

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Recruiting
NCT03299166Phase 2

Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder

Completed
NCT06034886

Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)

Unknown
NCT04641143Phase 3

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Completed
NCT03701399Phase 3

Troriluzole in Adult Participants With Spinocerebellar Ataxia

Active Not Recruiting
NCT02960893Phase 2

Trial in Adult Participants With Spinocerebellar Ataxia (SCA)

Completed
NCT06552260Early Phase 1

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Recruiting
NCT04693351Phase 3

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

Completed
NCT03829241Phase 3

Randomized Trial of Adult Participants With Generalized Anxiety Disorder

Completed
NCT04899921Phase 2

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

Terminated
NCT03605667Phase 2

Study of BHV-4157 in Alzheimer's Disease

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11